Clonazepam Mersifarma Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Clonazepam

Indications/Uses

As a single or additional drug in the treatment of Lennox-Gastaut syndrome. Patients w/ absence seizure (petit mal) who have not responded to succinimide.

Dosage/Direction for Use

Adult & Childn >10 yr (>30 kg) Initially 1-2 mg daily. Infant & childn <10 yr (≤30 kg) Initially 0.01-0.03 mg/kg daily. Maintenance Dose: Adult 2-4 mg daily. Chidln 10-16 yr (>30 kg) 1.5-3 mg daily. Infant & childn <10 yr (≤30 kg) 0.05-0.1 mg/kg daily. Max dose: 20 mg daily.

Contraindications

Hypersensitivity. Alcohol or drug dependence, acute narrow angle glaucoma, liver disease. Acute pulmonary disease, resp tract disorders, muscle weakness, myasthenia gravis.

Special Precautions

Chronic resp tract disorders. Avoid alcohol consumption; abrupt w/drawal. May impair the ability to drive vehicle or operate machinery. Liver & kidney diseases. Pregnancy, lactation. Childn.

Adverse Reactions

Fatigue, drowsiness, tiredness, dizziness, lightheadedness, ataxia. Resp depression on IV route. Increased salivation & bronchial secretion. W/drawal symptoms (after long-term use).

View ADR Monitoring Form

Drug Interactions

Increased serum level w/ phenytoin or pyrimidone. Combination w/ valproic acid may cause petit mal seizure. Concomitant use w/ barbiturate, hydantoin, or carbamazepine. Synergistic effect w/ other anticonvulsants, anaesth & hypnotic agents.

MIMS Class

Anticonvulsants

ATC Classification

N03AE01 - clonazepam ; Belongs to the class of benzodiazepine derivatives antiepileptic.

Regulatory Classification

Presentation/Packing

Form

Clonazepam Mersifarma FC tab 2 mg

Packing/Price

10 × 10's

Clonazepam Mersifarma

clonazepam

Manufacturer:

Mersifarma TM